As an alternative of going to the pharmacy to get the annual flu vaccine, many individuals within the US will now be capable of get it shipped to their door to take at residence themselves.
Beginning at the moment, AstraZeneca’s FluMist is out there by an online pharmacy in 34 states. FluMist is just not a brand new vaccine. It was initially authorized by the Meals and Drug Administration in 2003 and beforehand may solely be administered by a well being care skilled. However final September, the FDA mentioned the vaccine may very well be self-administered.
It’s AstraZeneca’s first foray into direct-to-consumer medication—a pattern being spearheaded by Novo Nordisk and Eli Lilly to promote their standard GLP-1 drugs for diabetes and weight administration to sufferers.
“We acknowledged that individuals’s each day lives are busier than ever, and we knew we wanted to satisfy folks the place they’re dealing with the realities of actual life,” mentioned Tonya Villafana, vice chairman of medical and scientific affairs at AstraZeneca, at a press convention on Thursday. “FluMist House is designed to take away conventional obstacles to vaccination, issues like scheduling clinic visits, ready in line, and the worry of needles.”
AstraZeneca is hoping that an at-home providing will assist increase flu vaccination charges. Solely about 47 p.c of adults get vaccinated towards flu, in response to the Centers for Disease Control and Prevention. Amongst kids, flu vaccination charges are dropping together with these of different routine childhood vaccines. As of April 26 this yr, 49.2 p.c of youngsters acquired a flu vaccination—decrease than 53.4 p.c on the identical time the earlier season, per the CDC.
“Getting vaccinated annually is the easiest way to forestall influenza, which causes sickness in a considerable proportion of the US inhabitants yearly and should lead to critical problems, together with hospitalization and loss of life,” mentioned Peter Marks, former director of the FDA’s Middle for Biologics Analysis and Analysis, in a statement final yr on FluMist’s approval for self-administration.
The CDC categorised the 2024-2025 flu season as excessive severity throughout all age teams within the US, leading to not less than 610,000 hospitalizations and 27,000 deaths. It was probably the most extreme flu season because the 2009 H1N1 swine flu pandemic.
AstraZeneca’s September 2024 approval was based mostly on a examine with vaccine recipients and caregivers to judge whether or not the directions to be used have been appropriately designed in order that they might safely and successfully use the vaccine.
The vaccine accommodates a weakened type of the reside influenza virus and protects towards 4 sorts of flu strains. It’s authorized for ages 2 by 49. For these beneath 18, it have to be administered by a caregiver.
To order, prospects might want to full a medical screening questionnaire. A licensed well being care supplier will overview every submission to find out eligibility. As soon as eligibility is confirmed and insurance coverage is verified, the vaccine can be prescribed and shipped on to the purchaser’s residence on a date they choose. FluMist is roofed by most insurance coverage, however customers might want to pay an $8.99 supply charge.
AstraZeneca says FluMist is just not but obtainable in all states because of native pharmacy legal guidelines, however the firm goals to have the ability to present the at-home spray to all of the contiguous states sooner or later. The vaccine will proceed to be obtainable in medical doctors’ workplaces and pharmacies for administration by well being care professionals throughout the nation.
